Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients

NCT04449380 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

56

Enrollment

OTHER

Sponsor class

Stopped Futility

Conditions

COVID-19 Virus Infection

Interventions

DRUG: Interferon-ß-1a
COMBINATION_PRODUCT: Standard of Care (SOC)

Sponsor

Emanuele Bosi